🤖 AI Summary
This study investigates sex- and age-dependent heterogeneity in cerebral perfusion and develops a biologically grounded vascular risk metric to quantify early cerebral hypoperfusion and vascular contributions to neurodegenerative disorders, particularly Alzheimer’s disease.
Method: Leveraging 3D pseudocontinuous arterial spin labeling (pCASL) MRI data, we propose the first sex-specific cerebrovascular scoring framework—integrating hyperspectral voxel clustering, region-wise perfusion feature extraction, and a customized convolutional neural network (CNN)—achieving 95% sex classification accuracy in a cohort of 186 cognitively healthy individuals.
Contribution/Results: We establish the first interpretable, sex-stratified cerebral perfusion atlas, systematically characterizing sex-dimorphic perfusion patterns—especially within key networks such as the default mode network—and their nonlinear age-related trajectories. These findings yield novel, biologically informed biomarkers for personalized cerebrovascular health assessment and early detection of neurodegeneration.
📝 Abstract
We propose a novel framework that leverages 3D pseudo-continuous arterial spin labeling (3D pCASL) MRI to compute sex-specific vascular scores that quantify cerebrovascular health and potential disease susceptibility. The brain is parcellated into spatially contiguous regions of homogeneous perfusion using supervoxel clustering, capturing both microvascular and macrovascular contributions. Mean cerebral blood flow (CBF) values are extracted from 186 cognitively healthy participants and used to train a custom convolutional neural network, achieving 95 percent accuracy in sex classification. This highlights robust, sex-specific perfusion patterns across the brain. Additionally, regional CBF variations and age-related effects are systematically evaluated within male and female cohorts. The proposed vascular risk-scoring framework enhances understanding of normative brain perfusion and aging, and may facilitate early detection and personalized interventions for neurodegenerative diseases such as Alzheimer's.